by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : September 2005
PBS LISTED New Testogel®: The fi rst gel containing testosterone for daily use Testogel is indicated for use as testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests. The recommended dose for adult men is 5g of gel applied once daily about the same time preferably in the morning. Depending on clinical/laboratory response, the daily dose can be adjusted by 2.5g steps to a maximum of 10g of gel per day. Apply to clean, dry healthy skin over either shoulder, or either arm or abdomen. It is not necessary to rub the gel into the skin. Allow at least 3-5 minutes for the gel to dry before dressing. Contraindications: Prostate/breast carcinoma, use in women/ children, hypersensitivity to testosterone or the gel. Precautions: Regular prostate monitoring. Patients with severe cardiac/hepatic/renal insufficiency, IHD, hypertension, epilepsy, migraine, hypercalcaemia. Risk of sleep apnoea. Testosterone transfer to others via skin contact.Potential interactions with oral anticoagulants, corticosteroids, oxyphenbutazone, buproprion, cyclosporin. Decreased insulin requirement. Adverse effects in addition to those already noted: Gynaecomastia/mastodynia, dizziness, parasthenia, amnesia, mood disorders, diarrhoea, alopecia, electrolyte changes, oligospermia, priapism. Review product information before prescribing. Full disclosure product information is available from Schering Pty Limited. PBS dispensed price for maximum quantity $96.41. Schering Pty Limited, ABN 50 000 023 361, Locked Bag 4, Alexandria, NSW 1435. Distributors for Schering AG, Germany. ®Registered Trademark. AU2005.0039 A6 07.05 PBS Information: Authority Required. Refer to PBS Schedule for full restricted benefit information. SC618 SC618 AJP TESTOGEL AD 270X206 indd 1 SC618 AJP TESTOGEL AD 270X206.indd. 15/8/05 1:09:13 PM 15/8/05 1:09:13 PM